Chronic hepatitis B in hepatocarcinogenesis

被引：64

作者：

Park, N. H.

Song, I. H.

Chung, Y-H

机构：

[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med,Div Gastroenterol, Seoul 138736, South Korea

[2] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Internal Med,Div Gastroenterol, Ulsan 680749, South Korea

[3] Dankook Univ Coll Med, Dept Internal Med, Div Gastroenterol, Cheonan, South Korea

来源：

POSTGRADUATE MEDICAL JOURNAL | 2006年 / 82卷 / 970期

关键词：

D O I：

10.1136/pgmj.2006.047431

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world, and has a wide geographical variation. Eighty per cent of HCC is attributed to hepatitis B virus (HBV). The predominant carcinogenic mechanism of HBV associated HCC is through the process of liver cirrhosis, but direct oncogenic effects of HBV may also contribute. Prevention of HBV infections as well as effective treatment of chronic hepatitis B is still needed for the global control of HBV associated HCC. Continued investigation of the mechanisms of hepatocarcinogenesis will refine our current understanding of the molecular and cellular basis for neoplastic transformation in the liver.

引用

收藏

页码：507 / 515

页数：9

相关论文

共 99 条

[71] Hepatitis B virus X protein inhibits transforming growth factor-β-induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway [J].

Shih, WL ;

Kuo, ML ;

Chuang, SE ;

Cheng, AL ;

Doong, SL .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (33) :25858-25864

[72]

Shin EC, 1999, INT J CANCER, V82, P587, DOI 10.1002/(SICI)1097-0215(19990812)82:4<587::AID-IJC19>3.0.CO

[73]

2-9

[74] Induction of apoptosis after switch-on of the hepatitis B virus X gene mediated by the Cre/loxP recombination system [J].

Shintani, Y ;

Yotsuyanagi, H ;

Moriya, K ;

Fujie, H ;

Tsutsumi, T ;

Kanegae, Y ;

Kimura, S ;

Saito, I ;

Koike, K .

JOURNAL OF GENERAL VIROLOGY, 1999, 80 :3257-3265

[75] Hepatitis B virus X protein induces cell death by causing loss of mitochondrial membrane potential [J].

Shirakata, Y ;

Koike, K .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (24) :22071-22078

[76] Transgenic mouse models of hepatitis B virus-associated hepatocellular carcinoma [J].

Singh, M ;

Kumar, V .

REVIEWS IN MEDICAL VIROLOGY, 2003, 13 (04) :243-253

[77] Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes [J].

Singh, RP ;

Agarwal, C ;

Agarwal, R .

CARCINOGENESIS, 2003, 24 (03) :555-563

[78] Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx [J].

Sirma, H ;

Giannini, C ;

Poussin, K ;

Paterlini, P ;

Kremsdorf, D ;

Bréchot, C .

ONCOGENE, 1999, 18 (34) :4848-4859

[79] Hypermodification and immune escape of an internally deleted middle-envelope (M) protein of frequent and predominant hepatitis B virus variants [J].

Tai, PC ;

Suk, FM ;

Gerlich, WH ;

Neurath, AR ;

Shih, C .

VIROLOGY, 2002, 292 (01) :44-58

[80]

Tanaka H, 2005, J GASTROEN HEPATOL, V20, P850, DOI [10.1111/j.1400-1746.2005.03823.x, 10.1111/j.1440-1746.2005.03823.x]

← 1 2 3 4 5 6 7 8 9 10 →